Treatment options in juvenile myoclonic epilepsy

Current Treatment Options in Neurology

Volumn 13, Issue 4, 2011, Pages 355-370

  Mantoan, Laura ^a   Walker, Matthew ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIMALARIAL AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; DIGOXIN; ESTROGEN; ETIRACETAM; LAMOTRIGINE; LEVONORGESTREL; METHYLDOPA; MUSCLE RELAXANT AGENT; NEUROLEPTIC AGENT; PHENOBARBITAL; PHENYTOIN; PLACEBO; PROGESTERONE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ACUTE DISEASE; AGGRESSION; ANOREXIA; APLASTIC ANEMIA; ARTICLE; ATAXIA; BEHAVIOR; BEHAVIOR DISORDER; BLOOD DISEASE; BONE MARROW DEPRESSION; BRAIN DEPTH STIMULATION; BRAIN SURGERY; CLOSED ANGLE GLAUCOMA; COGNITIVE DEFECT; CONFUSION; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DIPLOPIA; DISSEMINATED INTRAVASCULAR CLOTTING; DIZZINESS; DOSE RESPONSE; DROWSINESS; DRUG ANTAGONISM; DRUG BINDING; DRUG BLOOD LEVEL; DRUG COST; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG EXCRETION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG POTENTIATION; DRUG SAFETY; DYSPEPSIA; EVENING DOSAGE; FATIGUE; FEVER; GASTROINTESTINAL SYMPTOM; GRAND MAL SEIZURE; HAIR LOSS; HEADACHE; HUMAN; HYPERAMMONEMIA; INSOMNIA; IRRITABILITY; JUVENILE MYOCLONIC EPILEPSY; LETHARGY; LIVER DYSFUNCTION; LOW DRUG DOSE; LYMPHADENOPATHY; MEMORY DISORDER; MENSTRUATION DISORDER; MENTAL DISEASE; MOOD DISORDER; MYOCLONUS EPILEPSY; MYOCLONUS SEIZURE; MYOPIA; NAUSEA; NEPHROLITHIASIS; OVARY POLYCYSTIC DISEASE; PANCREATITIS; PANCYTOPENIA; PARESTHESIA; POSTOPERATIVE COMPLICATION; PROTEIN BINDING; RASH; RECOMMENDED DRUG DOSE; SEDATION; SIDE EFFECT; SOMNOLENCE; SPEECH DISORDER; STEVENS JOHNSON SYNDROME; THROMBOCYTOPENIA; TONIC CLONIC SEIZURE; TOXIC EPIDERMAL NECROLYSIS; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; TREMOR; VAGUS NERVE STIMULATION; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION; WITHDRAWAL SEIZURE;

EID: 80051669441     PISSN: 10928480     EISSN: 15343138     Source Type: Journal    
DOI: 10.1007/s11940-011-0131-z     Document Type: Article

References (49)

1. Panayiotopoulos C. The epilepsies bilateral seizures, syndromes and management. Oxfordshire: Bladon Medical Publishing; 2005. ISBN-10: 1-904218-34-2.
2. AG Marson AM Al-Kharusi M Alwaidh, et al. 2007 The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial Lancet 369 9566 1016 26 17382828 10.1016/S0140-6736(07)60461-9 1:CAS:528: DC%2BD2sXjsVSrur8%3D (Pubitemid 46436125)
3. S Calleja J Salas-Puig R Ribacoba CH Lahoz 2001 Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate Seizure 10 6 424 7 10.1053/seiz.2000.0530 11700996 1:STN:280:DC%2BD3MnkvFGlsg%3D%3D (Pubitemid 33114974)
4. A Nicolson RE Appleton DW Chadwick DF Smith 2004 The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies J Neurol Neurosurg Psychiatry 75 75 9 14707312 1:STN:280:DC%2BD2c%2FhtVahsQ%3D%3D (Pubitemid 38091272)
5. TS Walczak IE Leppik M D'Amelio, et al. 2001 Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study Neurology 56 4 519 25 11222798 1:STN:280:DC%2BD3M7ps1KgsQ%3D%3D (Pubitemid 32172879)
6. P Kwan MJ Brodie 2000 Early identification of refractory epilepsy N Engl J Med 342 5 314 319 10.1056/NEJM200002033420503 10660394 10.1056/ NEJM200002033420503 1:STN:280:DC%2BD3c7gs1KqtQ%3D%3D (Pubitemid 30075244)
7. J Morrow A Russell E Guthrie, et al. 2006 Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register J Neurol Neurosurg Psychiatry 77 2 193 198 10.1136/jnnp.2005.074203 16157661 10.1136/jnnp.2005.074203 1:STN:280: DC%2BD28%2FjtlGiug%3D%3D (Pubitemid 43220841)
8. C Knott CP Panayiotopoulos 1994 Carbamazepine in the treatment of generalised tonic clonic seizures in juvenile myoclonic epilepsy J Neurol Neurosurg Psychiatry 57 4 503 8164005 10.1136/jnnp.57.4.503 1:STN:280: DyaK2c3hs12jsg%3D%3D (Pubitemid 24118151)
9. MP Canevini R Mai CD Marco, et al. 1992 Juvenile myoclonic epilepsy of Janz: clinical observations in 60 patients Seizure 1 4 291 8 1344779 10.1016/1059-1311(92)90039-4 1:STN:280:DyaK2c3hsV2itw%3D%3D
10. PN Patsalos W Fröscher F Pisani CM van Rijn 2002 The importance of drug interactions in epilepsy therapy Epilepsia 43 4 365 85 11952767 10.1046/j.1528-1157.2002.13001.x 1:CAS:528:DC%2BD38XjtlSlur8%3D (Pubitemid 34297175)
11. L Bilo R Meo 2008 Polycystic ovary syndrome in women using valproate: a review Gynecol Endocrinol 24 10 562 570 10.1080/09513590802288259 19012099 10.1080/09513590802288259
12. DF Wyszynski M Nambisan T Surve, et al. 2005 Increased rate of major malformations in offspring exposed to valproate during pregnancy Neurology 64 6 961 5 15781808 1:CAS:528:DC%2BD2MXhvVShsLk%3D (Pubitemid 40388443)
13. JH DiLiberti PA Farndon NR Dennis CJ Curry 1984 The fetal valproate syndrome Am J Med Genet 19 3 473 481 10.1002/ajmg.1320190308 6439041 10.1002/ajmg.1320190308 1:STN:280:DyaL2M%2FmvFGrsg%3D%3D (Pubitemid 15205835)
14. U Kini N Adab J Vinten A Fryer J Clayton-Smith 2006 Liverpool and Manchester Neurodevelopmental Study Group: dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes Arch Dis Child Fetal Neonatal Ed 91 2 F90 5 16239295 10.1136/adc.2004.067421 1:STN:280:DC%2BD287jtlOruw%3D%3D (Pubitemid 43325524)
15. KJ Meador 2008 Effects of in utero antiepileptic drug exposure Epilepsy Curr 8 6 143 147 10.1111/j.1535-7511.2008.00273.x 19127305 10.1111/j.1535-7511. 2008.00273.x This is the first prospective, observational, multicenter study on neurodevelopmental outcomes after exposure to different antiepileptic drugs in utero; it showed that children exposed to valproate in utero have lower IQs than children exposed to phenytoin or carbamazepine.
16. SF Berkovic RC Knowlton RF Leroy J Schiemann U Falter 2007 Levetiracetam N01057 Study Group: placebo-controlled study of levetiracetam in idiopathic generalized epilepsy Neurology 69 18 1751 60 17625106 10.1212/01.wnl.0000268699. 34614.d3 1:CAS:528:DC%2BD2sXht1Shu7jJ (Pubitemid 350059304)
17. S Noachtar E Andermann P Meyvisch, et al. 2008 Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures Neurology 70 8 607 616 18285535 10.1212/01.wnl.0000297512.18364.40 1:CAS:528: DC%2BD1cXhs1Krurc%3D This well-designed, randomized, double-blind, placebo-controlled multicenter trial assessed the effectiveness of levetiracetam as add-on treatment in children and adults with IGE. (Pubitemid 351294638)
18. WE Rosenfeld S Benbadis P Edrich CA Tassinari E Hirsch 2009 Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies Epilepsy Res 85 72 80 10.1016/j.eplepsyres.2009.02.016 19327967 10.1016/j.eplepsyres.2009.02.016 1:CAS:528:DC%2BD1MXnt1eqs7o%3D This meta-analysis of two high-quality double-blind, placebo-controlled trials [16, 17•] demonstrates the effectiveness of levetiracetam as add-on treatment in IGE.
19. DG Kasteleijn-Nolst Trenité C Marescaux S Stodieck PM Edelbroek J Oosting 1996 Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam Epilepsy Res 25 3 225 230 8956920 10.1016/S0920-1211(96)00031-9 (Pubitemid 26394544)
20. MG Dahlin K Wide I Ohman 2010 Age and comedications influence levetiracetam pharmacokinetics in children Pediatr Neurol 43 4 231 235 10.1016/j.pediatrneurol.2010.05.008 20837299 10.1016/j.pediatrneurol.2010.05.008
21. S Hunt J Craig A Russell, et al. 2006 Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register Neurology 67 10 1876 1879 10.1212/01.wnl.0000244491.48937.55 17130430 10.1212/01.wnl. 0000244491.48937.55 1:CAS:528:DC%2BD28Xht1SjsL3K (Pubitemid 44900776)
22. Kennedy F, Morrow S, Hunt S, et al. PATH39 Malformation risks of antiepileptic drugs in pregnancy: an update from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2010;81:e18.
23. RG Beran SF Berkovic FM Dunagan, et al. 1998 Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy Epilepsia 39 12 1329 33 9860069 10.1111/j.1528-1157.1998. tb01332.x 1:CAS:528:DyaK1MXitFCisg%3D%3D (Pubitemid 29005633)
24. LM Frank T Enlow GL Holmes, et al. 1999 Lamictal (lamotrigine) monotherapy for typical absence seizures in children Epilepsia 40 7 973 9 10403222 10.1111/j.1528-1157.1999.tb00805.x 1:CAS:528:DyaK1MXmt1SjtLo%3D (Pubitemid 29316053)
25. A Biraben H Allain JM Scarabin S Schück G Edan 2000 Exacerbation of juvenile myoclonic epilepsy with lamotrigine Neurology 55 11 1758 11113246 1:STN:280:DC%2BD3M%2FnvFWitg%3D%3D
26. MJ Brodie AW Yuen 1997 Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group Epilepsy Res 26 3 423 32 9127723 10.1016/S0920-1211(96)01007-8 1:CAS:528:DyaK2sXivFGmtL0%3D (Pubitemid 27146300)
27. ML Zupanc 2006 Antiepileptic drugs and hormonal contraceptives in adolescent women with epilepsy Neurology 66 6 Suppl 3 S37 45 16567741 1:CAS:528:DC%2BD28XivFShsL0%3D
28. A Sabers I Ohman J Christensen T Tomson 2003 Oral contraceptives reduce lamotrigine plasma levels Neurology 61 4 570 1 12939444 1:CAS:528: DC%2BD3sXmtVemtr8%3D (Pubitemid 37025386)
29. I Wegner PM Edelbroek S Bulk D Lindhout 2009 Lamotrigine kinetics within the menstrual cycle, after menopause, and with oral contraceptives Neurology 73 17 1388 1393 10.1212/WNL.0b013e3181bd8295 19858461 10.1212/WNL.0b013e3181bd8295 1:CAS:528:DC%2BD1MXhtlegsb3N
30. LB Holmes EJ Baldwin CR Smith, et al. 2008 Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy Neurology 70 22 Pt 2 2152 2158 10.1212/01.wnl.0000304343.45104.d6 18448870 10.1212/01.wnl.0000304343.45104.d6 1:CAS:528:DC%2BD1cXmtV2ktb8%3D
31. P Tennis RR Eldridge 2002 International Lamotrigine Pregnancy Registry Scientific Advisory Committee: preliminary results on pregnancy outcomes in women using lamotrigine Epilepsia 43 10 1161 7 12366730 10.1046/j.1528-1157. 2002.45901.x 1:CAS:528:DC%2BD38Xos1Wgu70%3D (Pubitemid 35176122)
32. V Biton GD Montouris F Ritter, et al. 1999 A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group Neurology 52 7 1330 7 10227614 1:CAS:528:DyaK1MXivF2hs7w%3D (Pubitemid 29190520)
33. V Biton BFD Bourgeois 2005 YTC/YTCE Study Investigators: topiramate in patients with juvenile myoclonic epilepsy Arch Neurol 62 11 1705 8 16286543 10.1001/archneur.62.11.1705 (Pubitemid 41626666)
34. MD Privitera MJ Brodie RH Mattson, et al. 2003 Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy Acta Neurol Scand 107 3 165 75 12614309 10.1034/j.1600-0404.2003.00093.x 1:CAS:528:DC%2BD3sXjtVCgsrc%3D (Pubitemid 36398991)
35. S Hunt A Russell WH Smithson, et al. 2008 Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register Neurology 71 4 272 6 18645165 10.1212/01.wnl.0000318293.28278.33 1:CAS:528: DC%2BD1cXosFSrsr0%3D
36. S Hernández-Díaz R Mittendorf LB Holmes 2010 Comparative safety of topiramate during pregnancy [abstract] Birth Defects Research Part A 88 408
37. SV Kothare J Kaleyias N Mostofi, et al. 2006 Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy Pediatr Neurol 34 5 351 354 10.1016/j.pediatrneurol.2005.10.007 16647993 10.1016/j.pediatrneurol. 2005.10.007
38. A Marinas V Villanueva BG Giráldez, et al. 2009 Efficacy and tolerability of zonisamide in idiopathic generalized epilepsy Epileptic Disord 11 61 66 10.1684/epd.2009.0239 19264587
39. T Kondo S Kaneko Y Amano I Egawa 1996 Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy Epilepsia 37 12 1242 4 8956859 10.1111/j.1528-1157.1996.tb00560.x 1:CAS:528: DyaK2sXlsVCitA%3D%3D (Pubitemid 26415248)
40. T Obeid CP Panayiotopoulos 1989 Clonazepam in juvenile myoclonic epilepsy Epilepsia 30 5 603 6 2507306 10.1111/j.1528-1157.1989.tb05479.x 1:STN:280:DyaK3c%2FgsFehsQ%3D%3D (Pubitemid 19253104)
41. H Naito M Wachi M Nishida 1987 Clinical effects and plasma concentrations of long-term clonazepam monotherapy in previously untreated epileptics Acta Neurol Scand 76 58 63 3630646 10.1111/j.1600-0404.1987.tb03545.x 1:STN:280:DyaL2szit1egsg%3D%3D (Pubitemid 17138941)
42. B Mikkelsen E Birket-Smith S Bradt, et al. 1976 Clonazepam in the treatment of epilepsy. A controlled clinical trial in simple absences, bilateral massive epileptic myoclonus, and atonic seizures Arch Neurol 33 5 322 5 817696 1:STN:280:DyaE287otlOluw%3D%3D
43. M Feely J Gibson 1984 Intermittent clobazam for catamenial epilepsy: tolerance avoided J Neurol Neurosurg Psychiatry 47 12 1279 82 6392481 10.1136/jnnp.47.12.1279 1:STN:280:DyaL2M%2Fot1Wisg%3D%3D (Pubitemid 15178747)
44. AE Lin AJ Peller MN Westgate, et al. 2004 Clonazepam use in pregnancy and the risk of malformations Birth Defects Res A Clin Mol Teratol 70 8 534 536 10.1002/bdra.20051 15329832 10.1002/bdra.20051 1:CAS:528:DC%2BD2cXns1Sms7g%3D (Pubitemid 39167068)
45. H Kostov PG Larsson GK Røste 2007 Is vagus nerve stimulation a treatment option for patients with drug-resistant idiopathic generalized epilepsy? Acta Neurol Scand Suppl 187 55 58 10.1111/j.1600-0404.2007.00848.x 17419830 10.1111/j.1600-0404.2007.00848.x 1:STN:280:DC%2BD2s3hsFGmsg%3D%3D (Pubitemid 46535916)
46. P Boon M D'Havé PV Walleghem, et al. 2002 Direct medical costs of refractory epilepsy incurred by three different treatment modalities: a prospective assessment Epilepsia 43 96 102 11879393 10.1046/j.1528-1157.2002. 40100.x 1:STN:280:DC%2BD387ks1Cntg%3D%3D
47. M Nei M O'Connor J Liporace MR Sperling 2006 Refractory generalized seizures: response to corpus callosotomy and vagal nerve stimulation Epilepsia 47 115 122 10.1111/j.1528-1167.2006.00377.x 16417539 10.1111/j.1528-1167.2006. 00377.x
48. R Fisher V Salanova T Witt, et al. 2010 Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy Epilepsia 51 5 899 908 10.1111/j.1528-1167.2010.02536.x 20331461 This is the latest report from SANTE, a multicenter, double-blind, randomized trial, showing that stimulation of the anterior thalamic nuclei is effective in some forms of localization-related epilepsy.
49. JW Wheless DF Clarke A Arzimanoglou D Carpenter 2007 Treatment of pediatric epilepsy: European expert opinion, 2007 Epileptic Disord 9 4 353 412 10.1684/epd.2007.0144 18077226 (Pubitemid 351147653)